Evidence map›Paper›PMID 32850714›Full record

ArticleFrontiers in bioengineering and biotechnology2020

Preclinical Validation of SilkBridge

Federica Fregnan, Luisa Muratori, Giulia A Bassani, Alessandro Crosio, Marco Biagiotti, Valentina Vincoli, Giacomo Carta, Pasquale Pierimarchi, Stefano Geuna, Antonio Alessandrino and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Silk Bioconjugates: From Chemistry and Concept to Application.ACS biomaterials science & engineering · 2024
    Review
  6. Silk fibroin-based scaffolds for tissue engineering.Frontiers in bioengineering and biotechnology · 2024
    Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. TiFrontiers in bioengineering and biotechnology · 2022
    Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Federica FregnanDepartment of Clinical and Biological Sciences, University of Turin, Turin, Italy.
Luisa MuratoriDepartment of Clinical and Biological Sciences, University of Turin, Turin, Italy.
Giulia A BassaniSilk Biomaterials Srl, Lomazzo, Italy.
Alessandro CrosioDepartment of Clinical and Biological Sciences, University of Turin, Turin, Italy.
Marco BiagiottiSilk Biomaterials Srl, Lomazzo, Italy.
Valentina VincoliSilk Biomaterials Srl, Lomazzo, Italy.
Giacomo CartaDepartment of Clinical and Biological Sciences, University of Turin, Turin, Italy.
Pasquale PierimarchiInstitute of Translational Pharmacology, National Research Council, Rome, Italy.
Stefano GeunaDepartment of Clinical and Biological Sciences, University of Turin, Turin, Italy.
Antonio AlessandrinoSilk Biomaterials Srl, Lomazzo, Italy.
Giuliano FreddiSilk Biomaterials Srl, Lomazzo, Italy.
Giulia RonchiDepartment of Clinical and Biological Sciences, University of Turin, Turin, Italy.
Institute of Polymers, Composites and Biomaterials · ITNeuroscience Institute · ITUniversity of Turin · ITIstituto di Farmacologia Traslazionale · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Silk fibroin (

Indexed as

biodegradationfunctional recoveryin vivolong-term biocompatibilitymechanical propertiesnerve conduitnerve regenerationsilk fibroin

Identifiers

PMID32850714
PMCPMC7426473
OpenAlexW3048280175

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.